Multicell Technologies Stock

Multicell Technologies P/B

The P/B (Price-to-Book Ratio) of Multicell Technologies (MCET) as of Aug 7, 2026 is -0.03.

P/B

-0.03

Last updated:

P/B (Price-to-Book Ratio) of Multicell Technologies is 2026 -0.03 . P/B (Price-to-Book Ratio) of Multicell Technologies was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Multicell Technologies Stock analysis

What does Multicell Technologies do? Multicell Technologies Inc is a US-American company specialized in the development and production of innovative products in the field of biomedical and biotechnological research. The company was founded in 1987 by a team of scientists and has held a leading position in the industry ever since. They develop technologies for the isolation and artificial reproduction of cell cultures, collaborate with leading scientists and research institutions to develop new methods and products for fighting diseases such as cancer and cardiovascular diseases, and offer a wide range of products for biomedical and biotechnological research, including cell culture systems, antibody products, and specialized analysis tools. They also work on the production of cell lines and cultures and develop active therapeutics, including a program for developing a new therapeutic for multiple sclerosis. Additionally, they have a diagnostics business and have developed a special platform for DNA sequencing. Overall, Multicell Technologies Inc is known for its close collaboration with the scientific community and its dedication to developing innovative products for the medical field. Multicell Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Multicell Technologies stock

P/B (Price-to-Book Ratio) of Multicell Technologies is -0.03 in 2026.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Multicell Technologies since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Multicell Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Multicell Technologies

All Key Metrics — Multicell Technologies